<?xml version="1.0" encoding="UTF-8"?>
<ref id="ref30">
 <mixed-citation publication-type="journal" id="cit30">
  <name>
   <surname>Yang</surname>
   <given-names>Z.</given-names>
  </name>; 
  <name>
   <surname>Wang</surname>
   <given-names>J.-R.</given-names>
  </name>; 
  <name>
   <surname>Niu</surname>
   <given-names>T.</given-names>
  </name>; 
  <name>
   <surname>Gao</surname>
   <given-names>S.</given-names>
  </name>; 
  <name>
   <surname>Yin</surname>
   <given-names>T.</given-names>
  </name>; 
  <name>
   <surname>You</surname>
   <given-names>M.</given-names>
  </name>; 
  <name>
   <surname>Jiang</surname>
   <given-names>Z.-H.</given-names>
  </name>; 
  <name>
   <surname>Hu</surname>
   <given-names>M.</given-names>
  </name>
  <article-title>Inhibition of P-glycoprotein leads to improved oral bioavailability of compound K, an anticancer metabolite of red ginseng extract produced by gut microflora</article-title>. 
  <source>Drug Metab. Dispos.</source>
  <year>2012</year>, 
  <volume>40</volume>, 
  <fpage>1538</fpage>â€“
  <lpage>1544</lpage>. 
  <pub-id pub-id-type="doi">10.1124/dmd.111.044008</pub-id>.
  <pub-id pub-id-type="pmid">22584255</pub-id>
 </mixed-citation>
</ref>
